Trichomegaly following treatment with gefitinib (ZD1839).
about
Dermatological Side Effects of Epidermal Growth Factor Receptor Inhibitors: 'PRIDE' Complex.Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancerGefitinib-induced hair alterations.Eyelash trichomegaly following treatment with erlotinib in a non-small cell lung cancer patient: A case report and literature review.Gefitinib: an adverse effects profile.Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature reviewEyelash trichomegaly: review of congenital, acquired, and drug-associated etiologies for elongation of the eyelashes.Spectrum of ocular toxicities from epidermal growth factor receptor inhibitors and their intermediate-term follow-up: a five-year review.Biology of the eyelash hair follicle: an enigma in plain sight.Eyelash Trichomegaly.Epidermal growth factor receptor inhibitors related trichomegaly of Eyelashes.Erlotinib induced trichomegaly of the eyelashes.Hair repigmentation associated with the use of lenalidomide: graying may not be an irreversible process!Severe cutaneous toxicity following treatment with gefitinib (ZD1839).Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia.CME Part 1: Hair disorders in cancer patients.An unusual terminal hair growth on the nose tip associated with gefitinib therapy.
P2860
Q33683529-074297EB-094E-430B-9DF9-FC458C9D0E71Q33983656-2C1F4737-B112-437F-818F-53EC4A47156AQ34524343-3F853678-4EFC-4B7A-8188-225F848A0DD4Q35870274-149413F3-8B9B-4270-A924-D57461137E7FQ36446915-34B37E51-8A68-452B-824B-08B3C204D0EAQ37204363-26AD2845-049F-41A7-A6FF-173BB263A681Q38011241-C8F03193-04E6-44D4-93E4-66C4461485A9Q38059784-FB75492A-2F21-4CB2-9767-A16B34987204Q38603091-6F01B687-746A-4408-B6CF-B0FD04F78CBBQ42127047-857861C0-5C18-4B3E-AFB3-5AFA0CA8121CQ42180892-30DD0656-EEF8-4B08-9F06-527FC82717A4Q43154897-3522C147-9CB1-47A6-AED8-C0C062AE0D03Q45395629-6891C7D9-0DEB-4941-9A8A-0E0E48CA6C40Q46819918-DD47FADB-EA47-49CF-AA39-B8F1178D5B44Q50879467-1C043BC9-2651-4562-B7FB-0A5B8DB1BA79Q52585556-ACF64374-592F-4065-A110-2BCAD9A59657Q53574565-0BE91450-A28D-4F49-AABF-F9A2AD22824C
P2860
Trichomegaly following treatment with gefitinib (ZD1839).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Trichomegaly following treatment with gefitinib (ZD1839).
@en
Trichomegaly following treatment with gefitinib
@nl
type
label
Trichomegaly following treatment with gefitinib (ZD1839).
@en
Trichomegaly following treatment with gefitinib
@nl
prefLabel
Trichomegaly following treatment with gefitinib (ZD1839).
@en
Trichomegaly following treatment with gefitinib
@nl
P2093
P2860
P1476
Trichomegaly following treatment with gefitinib (ZD1839).
@en
P2093
P2860
P304
P356
10.1111/J.1365-2133.2004.06265.X
P407
P577
2004-11-01T00:00:00Z